Vimarsana
Biggest News Aggregation in the World

Page 44 - Human Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Use Today - Breaking & Trending Today

PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe - PTC Therapeutics (NASDAQ:PTCT) - Vimarsana News

PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe - PTC Therapeutics (NASDAQ:PTCT)

CHMP issues negative opinion on PTC Therapeutics' Translarna for Duchenne Muscular Dystrophy. CEO expresses disappointment.

European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer - Vimarsana News

European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer

/PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced that on Jan. 26, 2024...

Climate Change May Endanger Earth's Freshwater Resources, Threatening Drinking Water Supply For Millions - Vimarsana News

Climate Change May Endanger Earth's Freshwater Resources, Threatening Drinking Water Supply For Millions

An international study of temperature variations in 12 caves around the world shows that a large part of the Earth's freshwater reserves available for immediate consumption can be at risk due to climate change.

No decision from EU drug regulator yet on Wegovy label expansion - Vimarsana News

No decision from EU drug regulator yet on Wegovy label expansion

LONDON (Reuters) -The EU drug regulator on Friday did not mention Novo Nordisk's popular weight-loss drug Wegovy in notes it published following a meeting of a key committee, which reviewed the therapy's heart benefits this week. On Monday, the Europea...

Source: whbl.com
AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines Agency - Vimarsana News

AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines Agency

PRESS RELEASE AB SCIENCE ANNOUNCES AN UPDATE IN THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AT THE EUROPEAN MEDICINES AGENCY A DECISION FROM THE EUROPEAN...